Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Relation of Demographics and Reported Symptoms and Medication Use in Persons with Multiple Sclerosis.
Linked in and up to speed.
Orthopaedic Management of Spasticity.
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation.
Neurodegeneration: Active astrocytes drive inflammation.
Intraspinal transplantation of mouse and human neural precursor cells.
A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis.
Recurrent paraparesis and death of a patient with 'whippet' abuse.
Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
Prospective microglia and brain macrophage distribution pattern in normal rat brain shows age sensitive dispersal and stabilization with development.
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
[Clinical and magnetic resonance imaging features of neuromyelitis optics with positive anti-nuclear antibody serum].
[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
D313Y mutation in the differential diagnosis of white matter lesions: Experiences from a multiple sclerosis outpatient clinic.
Late-onset Multiple Sclerosis in Isfahan, Iran.
Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells.
Vitamin D, steroid hormones, and autoimmunity.
A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.
The Importance of Nitric Oxide and Arginase in the Pathogenesis of Acute Neuroinflammation: Are Those Contra Players with the Same Direction?
The protein arginine deiminases: Structure, function, inhibition, and disease.
Elevated Phospholipid Transfer Protein in Subjects with Multiple Sclerosis.
Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.
Progressive multifocal leukoencephalopathy in multiple sclerosis.
Pages
« first
‹ previous
…
507
508
509
510
511
512
513
514
515
…
next ›
last »